Vildagliptin/Metformin in T2DM Patients Starting Basal Insulin
Status:
Completed
Trial end date:
2015-02-01
Target enrollment:
Participant gender:
Summary
To compare a therapeutic strategy combining vildagliptin+metformin + Basal Insulin versus
SU+metformin + Basal Insulin on the incidence of hypoglycemic events over 24 weeks.